Application Number Funding Recommendation Title Score RL1-00667 Recommended New Technology ForThe Derivation of Human Pluripotent Stem Cell Lines For Clinical Use 85 RL1-00650 Recommended Establishment of Frontotemporal Dementia Patient-Specific Induced Pluripotent Stem (iPS) Cell Lines with Defined Genetic Mutations 85 RL1-00670 Recommended Derivation and comparative analysis of human pluripotent ESCs, iPSCs and SSCs: Convergence to an embryonic phenotype 82 RL1-00648 Recommended Optimization of Human Embryonic Stem Cell Derivation Techniques and Production/Distribution of GMP-Grade Lines 82 RL1-00636 Recommended Generation of Pluripotent Cell Lines from Human Embryos 82 RL1-00634 Recommended Safe, efficient creation of human induced pluripotent stem cells without the use of retroviruses 80 RL1-00662 Recommended Derivation and analysis of pluripotent stem cell lines with inherited TGF-b mediated disorders from donated IVF embryos and reprogrammed adult skin fibroblasts 79 RL1-00669 Recommended Somatic cell age and memory in the generation of iPS cells 78 RL1-00630 Recommended Derivation of hESC Lines with Disease Lesions 77 RL1-00681 Recommended Generation of clinical grade human iPS cells 74 RL1-00639 Recommended Induced Pluripotent Stem Cells for Cardiovascular Diagnostics 73 RL1-00644 Recommended Protein transduction of transcription factors: a non-genetic approach to generate new pluripotent cell lines from human skin. 73 RL1-00660 Recommended Induction of pluripotent stem cells by small RNA-guided transcriptional activation 71 RL1-00649 Recommended if funds allow Development of Induced Pluripotent Stem Cells for Modeling Human Disease 69 RL1-00678 Recommended if funds allow New Cell Lines for Huntington's Disease 69 RL1-00682 Recommended Derivation of Parkinson's Disease Coded-Stem Cells (PD-SCs) 67 RL1-00633 Not recommended High-fidelity derivation of new stem cell lines 67 RL1-00677 Not recommended Derivation of new induced pluripotent stem (iPS) cells to build neurological disease models 63 RL1-00675 Not recommended Generation of human embryonic stem cell lines, under defined conditions, modeling normal & diseased states from material stored at the {REDACTED} embryo bank 61 RL1-00631 Not recommended Generating pluripotent cell lines from human neurons. 0 RL1-00642-B Recommended Derivation of New ICM-stage hESCs 58 RL1-00642-A Recommended Derivation of New ICM-stage hESCs 58 RL1-00665 Not recommended Derivation of scalable clinical grade human embryonic stem cells under current Good Manufacturing Practice conditions using conventional and single blastomere biopsy protocols 0 RL1-00656 Not recommended Generation of human ESC lines using SCNT 0 RL1-00637 Not recommended Induced Pluripotent Stem Cell Lines from Retinal Pigment Epithelial Cells 0 RL1-00640 Not recommended Isolation and Characterization of A Novel Stem Cell Line from Amniotic Fluid and their Potential for Regenerative Medicine Applications 0 RL1-00657 Not recommended Creating the next generation of human iPS cells with global screens for and use of novel pluripotency factors 0 RL1-00635 Not recommended Derivation of human embryonic stem cell lines from human blastocysts: analysis of genetic stability and ethnic diversity 0 RL1-00647 Not recommended Establishing Noonan and Leopard syndrome patient-specific iPS cell lines 0 RL1-00674 Not recommended Derivation of new human pluripotent stem cells using small molecules 0 RL1-00659 Not recommended Establishment of Human Embryonic Stem Cells Modeling Human Disease by Somatic Cell Nuclear Transfer 0 RL1-00671 Not recommended Derivation of clinical grade HLA-homozygous human stem cell lines using parthenogenetic activation of oocytes 0 RL1-00652 Not recommended GENERATION OF PLURIPOTENT STEM CELL LINES FROM SPERMATOGONIAL STEM CELLS APPLICABLE TO REGENERATIVE MEDICINE 0 RL1-00683 Not recommended Generating Pluripotent Stem Cells from Skin of Patients with Multiple Sclerosis and Parkinson's Disease 0 RL1-00646 Not recommended Derivation of hESC lines from multi-pronuclei zygotes 0 RL1-00663 Not recommended Creating stem cells for treatment of neurological disease: a novel microRNA-based method for safe, efficient induction of pluripotence in patient-specific cells 0 RL1-00655 Not recommended Large-Scale Reprogramming of Human Somatic Cells to a Pluripotent Stem Cell-Like State 0 RL1-00668 Not recommended Derivation of Novel Late Onset Disease-Specific Stem Cell Lines Using Highly Accurate Single Cell Genotyping Technology 0 RL1-00641 Not recommended Generation and Testing of Induced Pluripotent Stem Cell Lines for Understanding Human Oligodendrocyte Development and Disease 0 RL1-00654 Not recommended Comparison of New Lines from Multiple Sources 0 RL1-00645 Not recommended Clinically Relevant iPS Cell Lines 0 RL1-00679 Not recommended Establishment of human embryonic stem cell lines using re-constructed human embryos derived from polyspermic eggs 0 RL1-00632 Not recommended Induction of iPS Cells Using Transient Episomal Expression Vectors: Validation of Toxicity Testing in iPS-Derived Hepatocytes. 0 RL1-00661 Not recommended Derivation of hES Cells in Novel Key Regulators of Cell Survival and Growth 0 RL1-00658 Not recommended Placental Derived Stem Cells 0 RL1-00653 Not recommended Derivation of New iPS Cell Lines and Development of a Novel Stem Cell Platform for Parkinson's Research and Therapeutic Applications 0 RL1-00638 Not recommended Human Germ-Line Stem Cells As Source for Pluripotent Stem Cells 0 RL1-00684 Not recommended Generation of an Engineered Insulin Reporter hES Cell Line to Facilitate Cell-Based Assays for Diabetes Research 0 RL1-00666 Not recommended Pluripotent human stem cells for creation of disease-specific and genotypically diverse 3-D liver tissues for drug discovery and patient therapies 0 RL1-00672 Not recommended In vitro and in vivo characterization of human neuronal precursor cells 0 RL1-00680 Not recommended MicroRNA (miRNA)-induced Pluripotent Stem Cells (mirPS) 0